NeonMind Biosciences Inc.
NeonMind Biosciences Inc. (NMDBF) Stock Competitors & Peer Comparison
See (NMDBF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NMDBF | $0.01 | +0.00% | 8.5K | -0.01 | -$1.31 | N/A |
| NONOF | $36.09 | +2.39% | 155.5B | 9.83 | $3.56 | +4.15% |
| CSLLY | $24.73 | +2.94% | 95B | 15.94 | $1.54 | +2.99% |
| UCBJY | $155.94 | +7.84% | 57.6B | 32.65 | $4.63 | +0.53% |
| UCBJF | $320.14 | +6.40% | 54.9B | 31.08 | $9.28 | +0.52% |
| CMXHF | $96.49 | +0.70% | 47.2B | 15.76 | $6.17 | +3.00% |
| ARGNF | $712.03 | +0.47% | 44.1B | 36.40 | $19.56 | N/A |
| WXIBF | $4.60 | +0.00% | 19B | 27.06 | $0.17 | N/A |
| IVBXF | $11.76 | +17.65% | 18.9B | 156.94 | $0.07 | N/A |
| WXXWY | $8.92 | +10.40% | 17.7B | 25.12 | $0.34 | N/A |
Stock Comparison
NMDBF vs NONOF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NONOF has a market cap of 155.5B. Regarding current trading prices, NMDBF is priced at $0.01, while NONOF trades at $36.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NONOF's P/E ratio is 9.83. In terms of profitability, NMDBF's ROE is +3.66%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, NMDBF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check NONOF's competition here
NMDBF vs CSLLY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CSLLY has a market cap of 95B. Regarding current trading prices, NMDBF is priced at $0.01, while CSLLY trades at $24.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CSLLY's P/E ratio is 15.94. In terms of profitability, NMDBF's ROE is +3.66%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, NMDBF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check CSLLY's competition here
NMDBF vs UCBJY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, UCBJY has a market cap of 57.6B. Regarding current trading prices, NMDBF is priced at $0.01, while UCBJY trades at $155.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas UCBJY's P/E ratio is 32.65. In terms of profitability, NMDBF's ROE is +3.66%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, NMDBF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check UCBJY's competition here
NMDBF vs UCBJF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, UCBJF has a market cap of 54.9B. Regarding current trading prices, NMDBF is priced at $0.01, while UCBJF trades at $320.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas UCBJF's P/E ratio is 31.08. In terms of profitability, NMDBF's ROE is +3.66%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, NMDBF and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
NMDBF vs CMXHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CMXHF has a market cap of 47.2B. Regarding current trading prices, NMDBF is priced at $0.01, while CMXHF trades at $96.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CMXHF's P/E ratio is 15.76. In terms of profitability, NMDBF's ROE is +3.66%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, NMDBF and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
NMDBF vs ARGNF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ARGNF has a market cap of 44.1B. Regarding current trading prices, NMDBF is priced at $0.01, while ARGNF trades at $712.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ARGNF's P/E ratio is 36.40. In terms of profitability, NMDBF's ROE is +3.66%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, NMDBF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
NMDBF vs WXIBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, NMDBF is priced at $0.01, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, NMDBF's ROE is +3.66%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, NMDBF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check WXIBF's competition here
NMDBF vs IVBXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, IVBXF has a market cap of 18.9B. Regarding current trading prices, NMDBF is priced at $0.01, while IVBXF trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas IVBXF's P/E ratio is 156.94. In terms of profitability, NMDBF's ROE is +3.66%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, NMDBF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
NMDBF vs WXXWY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, WXXWY has a market cap of 17.7B. Regarding current trading prices, NMDBF is priced at $0.01, while WXXWY trades at $8.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas WXXWY's P/E ratio is 25.12. In terms of profitability, NMDBF's ROE is +3.66%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, NMDBF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check WXXWY's competition here
NMDBF vs GNMSF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GNMSF has a market cap of 16.3B. Regarding current trading prices, NMDBF is priced at $0.01, while GNMSF trades at $265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GNMSF's P/E ratio is 17.25. In terms of profitability, NMDBF's ROE is +3.66%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, NMDBF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check GNMSF's competition here
NMDBF vs SBHMY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, NMDBF is priced at $0.01, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, NMDBF's ROE is +3.66%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, NMDBF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check SBHMY's competition here
NMDBF vs SBMFF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, NMDBF is priced at $0.01, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SBMFF's P/E ratio is 25.30. In terms of profitability, NMDBF's ROE is +3.66%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, NMDBF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
NMDBF vs BRRGF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, NMDBF is priced at $0.01, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, NMDBF's ROE is +3.66%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, NMDBF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BRRGF's competition here
NMDBF vs AAVXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, NMDBF is priced at $0.01, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, NMDBF's ROE is +3.66%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, NMDBF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
NMDBF vs ODTC Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, NMDBF is priced at $0.01, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ODTC's P/E ratio is 1.07. In terms of profitability, NMDBF's ROE is +3.66%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, NMDBF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
NMDBF vs AKBLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, NMDBF is priced at $0.01, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas AKBLF's P/E ratio is 37.32. In terms of profitability, NMDBF's ROE is +3.66%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, NMDBF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
NMDBF vs REGMF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, NMDBF is priced at $0.01, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas REGMF's P/E ratio is 57.63. In terms of profitability, NMDBF's ROE is +3.66%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, NMDBF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check REGMF's competition here
NMDBF vs TRSBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, NMDBF is priced at $0.01, while TRSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas TRSBF's P/E ratio is 18.64. In terms of profitability, NMDBF's ROE is +3.66%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, NMDBF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
NMDBF vs ABCZF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, NMDBF is priced at $0.01, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, NMDBF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
NMDBF vs LABFF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, NMDBF is priced at $0.01, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas LABFF's P/E ratio is 28.95. In terms of profitability, NMDBF's ROE is +3.66%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, NMDBF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
NMDBF vs SHJBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, NMDBF is priced at $0.01, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, NMDBF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
NMDBF vs CAMRF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, NMDBF is priced at $0.01, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CAMRF's P/E ratio is 41.98. In terms of profitability, NMDBF's ROE is +3.66%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, NMDBF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
NMDBF vs TLPPF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, TLPPF has a market cap of 3.2B. Regarding current trading prices, NMDBF is priced at $0.01, while TLPPF trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas TLPPF's P/E ratio is -467.50. In terms of profitability, NMDBF's ROE is +3.66%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, NMDBF and TLPPF have similar daily volatility (0.00).Check TLPPF's competition here
NMDBF vs ZLDPF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ZLDPF has a market cap of 3.2B. Regarding current trading prices, NMDBF is priced at $0.01, while ZLDPF trades at $44.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ZLDPF's P/E ratio is 3.20. In terms of profitability, NMDBF's ROE is +3.66%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, NMDBF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check ZLDPF's competition here
NMDBF vs ASPHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ASPHF has a market cap of 3.1B. Regarding current trading prices, NMDBF is priced at $0.01, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, NMDBF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
NMDBF vs BRCTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, NMDBF is priced at $0.01, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, NMDBF's ROE is +3.66%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, NMDBF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BRCTF's competition here
NMDBF vs GNNSF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GNNSF has a market cap of 2.8B. Regarding current trading prices, NMDBF is priced at $0.01, while GNNSF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GNNSF's P/E ratio is -5.20. In terms of profitability, NMDBF's ROE is +3.66%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, NMDBF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
NMDBF vs MPSYF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, NMDBF is priced at $0.01, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, NMDBF's ROE is +3.66%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, NMDBF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check MPSYF's competition here
NMDBF vs GENSF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GENSF has a market cap of 2.4B. Regarding current trading prices, NMDBF is priced at $0.01, while GENSF trades at $35.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GENSF's P/E ratio is 38.26. In terms of profitability, NMDBF's ROE is +3.66%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, NMDBF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check GENSF's competition here
NMDBF vs BVNRY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, NMDBF is priced at $0.01, while BVNRY trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BVNRY's P/E ratio is 10.91. In terms of profitability, NMDBF's ROE is +3.66%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, NMDBF and BVNRY have similar daily volatility (0.00).Check BVNRY's competition here
NMDBF vs BVNKF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BVNKF has a market cap of 2.3B. Regarding current trading prices, NMDBF is priced at $0.01, while BVNKF trades at $29.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BVNKF's P/E ratio is 10.92. In terms of profitability, NMDBF's ROE is +3.66%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, NMDBF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BVNKF's competition here
NMDBF vs INCPF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, NMDBF is priced at $0.01, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas INCPF's P/E ratio is 25.83. In terms of profitability, NMDBF's ROE is +3.66%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, NMDBF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check INCPF's competition here
NMDBF vs GLPGF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, NMDBF is priced at $0.01, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, NMDBF's ROE is +3.66%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, NMDBF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
NMDBF vs MEOBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, NMDBF is priced at $0.01, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, NMDBF's ROE is +3.66%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, NMDBF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
NMDBF vs ASCLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ASCLF has a market cap of 1.9B. Regarding current trading prices, NMDBF is priced at $0.01, while ASCLF trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ASCLF's P/E ratio is -45.25. In terms of profitability, NMDBF's ROE is +3.66%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, NMDBF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check ASCLF's competition here
NMDBF vs PHMMF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, NMDBF is priced at $0.01, while PHMMF trades at $96.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PHMMF's P/E ratio is 41.74. In terms of profitability, NMDBF's ROE is +3.66%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, NMDBF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
NMDBF vs BIESF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, NMDBF is priced at $0.01, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BIESF's P/E ratio is -44.44. In terms of profitability, NMDBF's ROE is +3.66%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, NMDBF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
NMDBF vs CSPHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, NMDBF is priced at $0.01, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CSPHF's P/E ratio is -25.25. In terms of profitability, NMDBF's ROE is +3.66%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, NMDBF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check CSPHF's competition here
NMDBF vs ONTTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ONTTF has a market cap of 1.4B. Regarding current trading prices, NMDBF is priced at $0.01, while ONTTF trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ONTTF's P/E ratio is -7.10. In terms of profitability, NMDBF's ROE is +3.66%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, NMDBF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check ONTTF's competition here
NMDBF vs HBMHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, NMDBF is priced at $0.01, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, NMDBF's ROE is +3.66%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, NMDBF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check HBMHF's competition here
NMDBF vs SNBIF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, NMDBF is priced at $0.01, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, NMDBF's ROE is +3.66%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, NMDBF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check SNBIF's competition here
NMDBF vs MDCLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, NMDBF is priced at $0.01, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, NMDBF's ROE is +3.66%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, NMDBF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
NMDBF vs CSBTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, NMDBF is priced at $0.01, while CSBTF trades at $27.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CSBTF's P/E ratio is 347.38. In terms of profitability, NMDBF's ROE is +3.66%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, NMDBF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
NMDBF vs PHGUF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, NMDBF is priced at $0.01, while PHGUF trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PHGUF's P/E ratio is -151.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, NMDBF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check PHGUF's competition here
NMDBF vs NURPF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, NMDBF is priced at $0.01, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NURPF's P/E ratio is 51.38. In terms of profitability, NMDBF's ROE is +3.66%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, NMDBF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
NMDBF vs IDRSF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, IDRSF has a market cap of 1B. Regarding current trading prices, NMDBF is priced at $0.01, while IDRSF trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas IDRSF's P/E ratio is -6.20. In terms of profitability, NMDBF's ROE is +3.66%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, NMDBF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check IDRSF's competition here
NMDBF vs PPTDF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, NMDBF is priced at $0.01, while PPTDF trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PPTDF's P/E ratio is -43.06. In terms of profitability, NMDBF's ROE is +3.66%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, NMDBF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check PPTDF's competition here
NMDBF vs BTTAY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, NMDBF is priced at $0.01, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, NMDBF's ROE is +3.66%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, NMDBF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BTTAY's competition here
NMDBF vs TKBIF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, NMDBF is priced at $0.01, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, NMDBF's ROE is +3.66%, compared to TKBIF's ROE of N/A. Regarding short-term risk, NMDBF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check TKBIF's competition here
NMDBF vs BPMUF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, NMDBF is priced at $0.01, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, NMDBF's ROE is +3.66%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, NMDBF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
NMDBF vs IVEVF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, NMDBF is priced at $0.01, while IVEVF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas IVEVF's P/E ratio is -1.27. In terms of profitability, NMDBF's ROE is +3.66%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, NMDBF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
NMDBF vs VBIZF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, NMDBF is priced at $0.01, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, NMDBF's ROE is +3.66%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, NMDBF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check VBIZF's competition here
NMDBF vs CKDXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, NMDBF is priced at $0.01, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, NMDBF's ROE is +3.66%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, NMDBF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check CKDXF's competition here
NMDBF vs INRLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, INRLF has a market cap of 538.6M. Regarding current trading prices, NMDBF is priced at $0.01, while INRLF trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas INRLF's P/E ratio is -3.96. In terms of profitability, NMDBF's ROE is +3.66%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, NMDBF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check INRLF's competition here
NMDBF vs GNFTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GNFTF has a market cap of 521.9M. Regarding current trading prices, NMDBF is priced at $0.01, while GNFTF trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GNFTF's P/E ratio is -11.59. In terms of profitability, NMDBF's ROE is +3.66%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, NMDBF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check GNFTF's competition here
NMDBF vs SOLTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SOLTF has a market cap of 477.8M. Regarding current trading prices, NMDBF is priced at $0.01, while SOLTF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SOLTF's P/E ratio is -6.07. In terms of profitability, NMDBF's ROE is +3.66%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, NMDBF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check SOLTF's competition here
NMDBF vs RAONF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, NMDBF is priced at $0.01, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas RAONF's P/E ratio is -43.33. In terms of profitability, NMDBF's ROE is +3.66%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, NMDBF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check RAONF's competition here
NMDBF vs GNFTY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, NMDBF is priced at $0.01, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, NMDBF's ROE is +3.66%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, NMDBF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check GNFTY's competition here
NMDBF vs TBGNF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, NMDBF is priced at $0.01, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, NMDBF's ROE is +3.66%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, NMDBF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
NMDBF vs CLVLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, NMDBF is priced at $0.01, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, NMDBF's ROE is +3.66%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, NMDBF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
NMDBF vs AVCTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, AVCTF has a market cap of 379.3M. Regarding current trading prices, NMDBF is priced at $0.01, while AVCTF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas AVCTF's P/E ratio is -5.78. In terms of profitability, NMDBF's ROE is +3.66%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, NMDBF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check AVCTF's competition here
NMDBF vs PTCHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, NMDBF is priced at $0.01, while PTCHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, NMDBF's ROE is +3.66%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, NMDBF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
NMDBF vs CLVLY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CLVLY has a market cap of 363.5M. Regarding current trading prices, NMDBF is priced at $0.01, while CLVLY trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CLVLY's P/E ratio is 16.45. In terms of profitability, NMDBF's ROE is +3.66%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, NMDBF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
NMDBF vs CYDY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CYDY has a market cap of 345.5M. Regarding current trading prices, NMDBF is priced at $0.01, while CYDY trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CYDY's P/E ratio is -9.07. In terms of profitability, NMDBF's ROE is +3.66%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, NMDBF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check CYDY's competition here
NMDBF vs NGENF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, NMDBF is priced at $0.01, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NGENF's P/E ratio is -15.19. In terms of profitability, NMDBF's ROE is +3.66%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, NMDBF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check NGENF's competition here
NMDBF vs NWBO Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NWBO has a market cap of 310.1M. Regarding current trading prices, NMDBF is priced at $0.01, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NWBO's P/E ratio is -3.35. In terms of profitability, NMDBF's ROE is +3.66%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, NMDBF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check NWBO's competition here
NMDBF vs FGHQF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, NMDBF is priced at $0.01, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, NMDBF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
NMDBF vs PBBIF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, NMDBF is priced at $0.01, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, NMDBF's ROE is +3.66%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, NMDBF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
NMDBF vs SLNCF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, NMDBF is priced at $0.01, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, NMDBF's ROE is +3.66%, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, NMDBF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
NMDBF vs SPHDF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SPHDF has a market cap of 275.5M. Regarding current trading prices, NMDBF is priced at $0.01, while SPHDF trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SPHDF's P/E ratio is -2.92. In terms of profitability, NMDBF's ROE is +3.66%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, NMDBF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
NMDBF vs ORPOF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, NMDBF is priced at $0.01, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, NMDBF's ROE is +3.66%, compared to ORPOF's ROE of N/A. Regarding short-term risk, NMDBF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
NMDBF vs ORYZF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, NMDBF is priced at $0.01, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, NMDBF's ROE is +3.66%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, NMDBF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check ORYZF's competition here
NMDBF vs HLOSF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, HLOSF has a market cap of 254.6M. Regarding current trading prices, NMDBF is priced at $0.01, while HLOSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas HLOSF's P/E ratio is -7.33. In terms of profitability, NMDBF's ROE is +3.66%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, NMDBF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
NMDBF vs HNSBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, NMDBF is priced at $0.01, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas HNSBF's P/E ratio is -4.14. In terms of profitability, NMDBF's ROE is +3.66%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, NMDBF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check HNSBF's competition here
NMDBF vs NWPHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NWPHF has a market cap of 239.6M. Regarding current trading prices, NMDBF is priced at $0.01, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NWPHF's P/E ratio is N/A. In terms of profitability, NMDBF's ROE is +3.66%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, NMDBF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
NMDBF vs CMVLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, NMDBF is priced at $0.01, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CMVLF's P/E ratio is -9.33. In terms of profitability, NMDBF's ROE is +3.66%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, NMDBF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
NMDBF vs CAIHF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, NMDBF is priced at $0.01, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, NMDBF's ROE is +3.66%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, NMDBF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check CAIHF's competition here
NMDBF vs BOVNF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, NMDBF is priced at $0.01, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, NMDBF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BOVNF's competition here
NMDBF vs FPHAF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, NMDBF is priced at $0.01, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, NMDBF's ROE is +3.66%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, NMDBF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
NMDBF vs KNTPF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, KNTPF has a market cap of 202.9M. Regarding current trading prices, NMDBF is priced at $0.01, while KNTPF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas KNTPF's P/E ratio is -7.21. In terms of profitability, NMDBF's ROE is +3.66%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, NMDBF is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check KNTPF's competition here
NMDBF vs MLLCF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, MLLCF has a market cap of 185.6M. Regarding current trading prices, NMDBF is priced at $0.01, while MLLCF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas MLLCF's P/E ratio is -2.38. In terms of profitability, NMDBF's ROE is +3.66%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, NMDBF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check MLLCF's competition here
NMDBF vs ADOCY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, NMDBF is priced at $0.01, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, NMDBF's ROE is +3.66%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, NMDBF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
NMDBF vs SCNLF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SCNLF has a market cap of 151.1M. Regarding current trading prices, NMDBF is priced at $0.01, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SCNLF's P/E ratio is -14.56. In terms of profitability, NMDBF's ROE is +3.66%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, NMDBF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
NMDBF vs ATGGF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ATGGF has a market cap of 143.7M. Regarding current trading prices, NMDBF is priced at $0.01, while ATGGF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ATGGF's P/E ratio is N/A. In terms of profitability, NMDBF's ROE is +3.66%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, NMDBF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check ATGGF's competition here
NMDBF vs AMGXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, NMDBF is priced at $0.01, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, NMDBF's ROE is +3.66%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, NMDBF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check AMGXF's competition here
NMDBF vs NDTP Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, NDTP has a market cap of 140.8M. Regarding current trading prices, NMDBF is priced at $0.01, while NDTP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas NDTP's P/E ratio is -3.14. In terms of profitability, NMDBF's ROE is +3.66%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, NMDBF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check NDTP's competition here
NMDBF vs BBIXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BBIXF has a market cap of 140.2M. Regarding current trading prices, NMDBF is priced at $0.01, while BBIXF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BBIXF's P/E ratio is -12.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, NMDBF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BBIXF's competition here
NMDBF vs SPHRF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SPHRF has a market cap of 138.6M. Regarding current trading prices, NMDBF is priced at $0.01, while SPHRF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SPHRF's P/E ratio is -33.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, NMDBF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
NMDBF vs BRIBF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, NMDBF is priced at $0.01, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas BRIBF's P/E ratio is -4.70. In terms of profitability, NMDBF's ROE is +3.66%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, NMDBF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check BRIBF's competition here
NMDBF vs HBPCF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, NMDBF is priced at $0.01, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, NMDBF's ROE is +3.66%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, NMDBF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
NMDBF vs TRGNF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, NMDBF is priced at $0.01, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, NMDBF's ROE is +3.66%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, NMDBF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check TRGNF's competition here
NMDBF vs IPHYF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, NMDBF is priced at $0.01, while IPHYF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas IPHYF's P/E ratio is -2.11. In terms of profitability, NMDBF's ROE is +3.66%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, NMDBF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
NMDBF vs JWCTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, JWCTF has a market cap of 127.8M. Regarding current trading prices, NMDBF is priced at $0.01, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas JWCTF's P/E ratio is -1.62. In terms of profitability, NMDBF's ROE is +3.66%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, NMDBF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check JWCTF's competition here
NMDBF vs AAPGV Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, NMDBF is priced at $0.01, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas AAPGV's P/E ratio is N/A. In terms of profitability, NMDBF's ROE is +3.66%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, NMDBF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check AAPGV's competition here
NMDBF vs SPHRY Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, SPHRY has a market cap of 126M. Regarding current trading prices, NMDBF is priced at $0.01, while SPHRY trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas SPHRY's P/E ratio is -60.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, NMDBF and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
NMDBF vs PSTTF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, NMDBF is priced at $0.01, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, NMDBF's ROE is +3.66%, compared to PSTTF's ROE of N/A. Regarding short-term risk, NMDBF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
NMDBF vs EPRXF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, NMDBF is priced at $0.01, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, NMDBF's ROE is +3.66%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, NMDBF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check EPRXF's competition here
NMDBF vs ADOIF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, NMDBF is priced at $0.01, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, NMDBF's ROE is +3.66%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, NMDBF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
NMDBF vs INNMF Comparison April 2026
NMDBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMDBF stands at 8.5K. In comparison, INNMF has a market cap of 94.9M. Regarding current trading prices, NMDBF is priced at $0.01, while INNMF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMDBF currently has a P/E ratio of -0.01, whereas INNMF's P/E ratio is -18.50. In terms of profitability, NMDBF's ROE is +3.66%, compared to INNMF's ROE of -0.24%. Regarding short-term risk, NMDBF is less volatile compared to INNMF. This indicates potentially lower risk in terms of short-term price fluctuations for NMDBF.Check INNMF's competition here